Prevalence and Cellular Distribution of Novel Immune Checkpoint Targets Across Longitudinal Specimens in Treatment-Naïve Melanoma: Implications for Clinical Trials
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-4011
Full Text
Open PDFAbstract
Available in full text
Date
February 18, 2019
Authors
Publisher
American Association for Cancer Research (AACR)